Trials / Withdrawn
WithdrawnNCT05935566
Impact of a History of Tonsillectomy or Adenoidectomy on the Severity of COVID-19 : AMYVID Study
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- University Hospital, Angers · Other Government
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Little is known about the impact of tonsillectomy and/or adenoidectomy on the severity and presentation of respiratory infections, let alone COVID-19. Current knowledge of the role of NALT suggests that its absence may be associated with an increased risk of severe disease. Assessing the impact of tonsillectomy and adenoidectomy on the risk of adverse evolution in COVID-19 would help to better identify patients at risk of adverse evolution, so that they can be rapidly offered appropriate treatment. It would also provide a better understanding of the pathophysiology of this infection. Primary objective: to determine whether there is a link between a history of tonsillectomy or adenoidectomy and the risk of severe COVID-19. Primary endpoint: proportion of patients with a history of tonsillectomy or adenoidectomy among those hospitalized for severe COVID-19. The results of this study will be compared with a data-driven study of Covid patients without severe disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | health questionnaire | Telephone interview with patient to verify medical history, including tonsillectomy and adenoidectomy. |
Timeline
- Start date
- 2024-03-01
- Primary completion
- 2024-03-01
- Completion
- 2024-03-01
- First posted
- 2023-07-07
- Last updated
- 2024-08-16
Source: ClinicalTrials.gov record NCT05935566. Inclusion in this directory is not an endorsement.